2/27
02:38 pm
cgon
CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M [Seeking Alpha]
Neutral
Report
CG Oncology GAAP EPS of -$2.08 beats by $0.09, revenue of $4.04M beats by $1.24M [Seeking Alpha]
2/27
02:22 pm
cgon
CG Oncology (CGON) had its price target raised by HC Wainwright from $75.00 to $80.00. They now have a "buy" rating on the stock.
Low
Report
CG Oncology (CGON) had its price target raised by HC Wainwright from $75.00 to $80.00. They now have a "buy" rating on the stock.
2/27
08:50 am
cgon
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates [Yahoo! Finance]
Medium
Report
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates [Yahoo! Finance]
2/27
08:30 am
cgon
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
Medium
Report
CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates
2/23
08:25 am
cgon
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
Low
Report
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference [Yahoo! Finance]
2/23
08:00 am
cgon
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
Low
Report
CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference
2/22
11:50 pm
cgon
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
Low
Report
Assessing CG Oncology (CGON) Valuation After Strong Recent Share Price Momentum [Yahoo! Finance]
2/10
08:05 am
cgon
CG Oncology (NASDAQ:CGON) had its price target raised by analysts at Truist Financial Corporation from $66.00 to $75.00. They now have a "buy" rating on the stock.
Medium
Report
CG Oncology (NASDAQ:CGON) had its price target raised by analysts at Truist Financial Corporation from $66.00 to $75.00. They now have a "buy" rating on the stock.
1/21
07:17 am
cgon
CG Oncology (NASDAQ:CGON) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
Medium
Report
CG Oncology (NASDAQ:CGON) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.
1/12
07:17 am
cgon
CG Oncology (NASDAQ:CGON) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Low
Report
CG Oncology (NASDAQ:CGON) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
1/11
08:38 am
cgon
CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene [Seeking Alpha]
Low
Report
CG Oncology: 'Strong Buy' On Earlier Than Expected Completed Recruitment Cretostimogene [Seeking Alpha]
1/10
07:02 pm
cgon
CG Oncology (CGON) Is Up 29.7% After Accelerating PIVOT-006 Phase 3 Timeline - Has The Bull Case Changed? [Yahoo! Finance]
Low
Report
CG Oncology (CGON) Is Up 29.7% After Accelerating PIVOT-006 Phase 3 Timeline - Has The Bull Case Changed? [Yahoo! Finance]
1/9
10:41 pm
cgon
Is CG Oncology (CGON) Stock Pricing In Its Recent 79% One Year Surge? [Yahoo! Finance]
Low
Report
Is CG Oncology (CGON) Stock Pricing In Its Recent 79% One Year Surge? [Yahoo! Finance]
1/9
04:07 pm
cgon
CG Oncology (NASDAQ:CGON) was given a new $93.00 price target on by analysts at Morgan Stanley.
Low
Report
CG Oncology (NASDAQ:CGON) was given a new $93.00 price target on by analysts at Morgan Stanley.
1/9
04:07 pm
cgon
CG Oncology (NASDAQ:CGON) was given a new $66.00 price target on by analysts at Truist Financial Corporation.
Low
Report
CG Oncology (NASDAQ:CGON) was given a new $66.00 price target on by analysts at Truist Financial Corporation.
1/9
08:43 am
cgon
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC [Yahoo! Finance]
High
Report
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC [Yahoo! Finance]
1/9
08:30 am
cgon
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
High
Report
CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC
1/8
08:42 am
cgon
CG Oncology (NASDAQ:CGON) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
CG Oncology (NASDAQ:CGON) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
1/6
08:00 am
cgon
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
Low
Report
CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
12/23
04:44 am
cgon
CG Oncology Undervalued Going Into A Busy 2026 [Seeking Alpha]
Low
Report
CG Oncology Undervalued Going Into A Busy 2026 [Seeking Alpha]
12/18
08:00 am
cgon
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
Low
Report
SUO-CTC and CG Oncology Announce the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
12/11
08:43 am
cgon
CG Oncology (NASDAQ:CGON) is now covered by analysts at Wedbush. They set an "outperform" rating and a $70.00 price target on the stock.
Low
Report
CG Oncology (NASDAQ:CGON) is now covered by analysts at Wedbush. They set an "outperform" rating and a $70.00 price target on the stock.
12/9
05:37 pm
cgon
How Positive Cretostimogene Trial Updates And Leadership Moves At CG Oncology (CGON) Have Changed Its Investment Story [Yahoo! Finance]
Low
Report
How Positive Cretostimogene Trial Updates And Leadership Moves At CG Oncology (CGON) Have Changed Its Investment Story [Yahoo! Finance]
12/9
12:27 am
cgon
CG Oncology, Inc. (CGON) is a Buy on Cancer Treatment Development: Truist Securities [Yahoo! Finance]
Low
Report
CG Oncology, Inc. (CGON) is a Buy on Cancer Treatment Development: Truist Securities [Yahoo! Finance]